Variant-divergent death: Omicron intensifies bystander T-cell apoptosis via GDF15-BCL2L13

Area of Science:

• Immunology
• Virology
• Cell Biology

Background:

• Severe Omicron variant cases exhibit significant lymphocytopenia, indicating a unique immune response.
• Understanding the mechanisms behind Omicron-induced T-cell depletion is crucial for managing severe COVID-19.

Purpose of the Study:

• To identify host factors involved in SARS-CoV-2 entry and T-cell apoptosis.
• To elucidate the role of GDF15 and BCL2L13 in Omicron-mediated immune injury.
• To correlate molecular findings with clinical outcomes in patients with severe COVID-19.

Main Methods:

• Investigated CD63 as a T-cell host factor for ACE2-independent SARS-CoV-2 entry.
• Assessed T-cell apoptosis mechanisms, including bystander effects, in response to Omicron.
• Analyzed the function of GDF15 and BCL2L13 in T-cell apoptosis using recombinant proteins and genetic manipulation.
• Correlated plasma GDF15 levels with clinical severity markers (mortality, SOFA scores, lymphocyte counts) in patient samples.

Main Results:

• CD63 was identified as a conserved T-cell host factor facilitating ACE2-independent SARS-CoV-2 entry.
• Omicron infection induced enhanced T-cell apoptosis via a bystander mechanism, distinct from ancestral strains.
• Omicron-stimulated epithelial cells secreted GDF15, which upregulated BCL2L13 in T cells, promoting bystander apoptosis.
• Elevated GDF15 levels in patient plasma were associated with increased mortality, SOFA scores, and lymphocytopenia.

Conclusions:

• A two-track model of Omicron immune injury was proposed: CD63-mediated T-cell entry and GDF15-BCL2L13-driven bystander apoptosis.
• This model explains reduced epithelial cell damage alongside severe T-cell depletion in critical illness.
• The GDF15-BCL2L13 axis represents a potential therapeutic target and a mechanistic biomarker for severe COVID-19.